Literature DB >> 22841910

Nanoparticle uptake in tumors is mediated by the interplay of vascular and collagen density with interstitial pressure.

Sason Torosean1, Brendan Flynn, Johan Axelsson, Jason Gunn, Kimberley S Samkoe, Tayyaba Hasan, Marvin M Doyley, Brian W Pogue.   

Abstract

Nanoparticle delivery into solid tumors is affected by vessel density, interstitial fluid pressure (IFP) and collagen, as shown in this article by contrasting the in vivo macroscopic quantitative uptake of 40 nm fluorescent beads in three tumor types.The fluorescence uptake was quantified on individual animals by normalization with the transmitted light and then normalized to normal tissue uptake in each mouse. Mean data for uptake in individual tumor lines then showed expected trends with the largest uptake in the most vascularized tumor line. Tumor lines with increased collagen were also consistent with highest interstitial fluid pressure and correlated with lowest uptake of nanoparticles. The data is consistent with a delivery model indicating that while vascular permeability is maximized by neovascular growth, it is inhibited by collagen content and the resulting interstitial pressure. Imaging of these parameters in vivo can lead to better individual noninvasive methods to assess drug penetration in situ. FROM THE CLINICAL EDITOR: In this manuscript the dependence of nanoparticle delivery is addressed from the standpoint of vascular factors (the more vascularized, the better delivery) and as a function of collagen density and interstitial pressure (the higher these are, the worse the delivery).
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22841910      PMCID: PMC3505807          DOI: 10.1016/j.nano.2012.07.002

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  38 in total

Review 1.  Strategies in the design of nanoparticles for therapeutic applications.

Authors:  Robby A Petros; Joseph M DeSimone
Journal:  Nat Rev Drug Discov       Date:  2010-07-09       Impact factor: 84.694

2.  Magnetic resonance-coupled fluorescence tomography scanner for molecular imaging of tissue.

Authors:  Scott C Davis; Brian W Pogue; Roger Springett; Christoph Leussler; Peter Mazurkewitz; Stephen B Tuttle; Summer L Gibbs-Strauss; Shudong S Jiang; Hamid Dehghani; Keith D Paulsen
Journal:  Rev Sci Instrum       Date:  2008-06       Impact factor: 1.523

3.  Ultrasound elastography as an adjuvant to conventional ultrasound in the preoperative assessment of axillary lymph nodes in suspected breast cancer: a pilot study.

Authors:  K Taylor; S O'Keeffe; P D Britton; M G Wallis; G M Treece; J Housden; D Parashar; S Bond; R Sinnatamby
Journal:  Clin Radiol       Date:  2011-08-11       Impact factor: 2.350

4.  Role of the extracellular matrix in cancer.

Authors:  L A Liotta; C N Rao
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

5.  Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging.

Authors:  A Krtolica; S Parrinello; S Lockett; P Y Desprez; J Campisi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

Review 6.  Barriers to drug delivery in solid tumors.

Authors:  R K Jain
Journal:  Sci Am       Date:  1994-07       Impact factor: 2.142

Review 7.  Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth.

Authors:  Dalit Barkan; Jeffrey E Green; Ann F Chambers
Journal:  Eur J Cancer       Date:  2010-03-19       Impact factor: 9.162

8.  Matrix crosslinking forces tumor progression by enhancing integrin signaling.

Authors:  Kandice R Levental; Hongmei Yu; Laura Kass; Johnathon N Lakins; Mikala Egeblad; Janine T Erler; Sheri F T Fong; Katalin Csiszar; Amato Giaccia; Wolfgang Weninger; Mitsuo Yamauchi; David L Gasser; Valerie M Weaver
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

Review 9.  Drug delivery and transport to solid tumors.

Authors:  Seong Hoon Jang; M Guillaume Wientjes; Dan Lu; Jessie L S Au
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

10.  Thermal ablation of tumors using magnetic nanoparticles: an in vivo feasibility study.

Authors:  Ingrid Hilger; Robert Hiergeist; Rudolf Hergt; Klaus Winnefeld; Harald Schubert; Werner A Kaiser
Journal:  Invest Radiol       Date:  2002-10       Impact factor: 6.016

View more
  22 in total

Review 1.  Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by Fluorescence.

Authors:  Alyssa B Chinen; Chenxia M Guan; Jennifer R Ferrer; Stacey N Barnaby; Timothy J Merkel; Chad A Mirkin
Journal:  Chem Rev       Date:  2015-08-27       Impact factor: 60.622

Review 2.  Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors.

Authors:  Lei Miao; C Michael Lin; Leaf Huang
Journal:  J Control Release       Date:  2015-08-12       Impact factor: 9.776

3.  Biodistribution and clearance of a filamentous plant virus in healthy and tumor-bearing mice.

Authors:  Sourabh Shukla; Amy M Wen; Nadia R Ayat; Ulrich Commandeur; Ramamurthy Gopalkrishnan; Ann-Marie Broome; Kristen W Lozada; Ruth A Keri; Nicole F Steinmetz
Journal:  Nanomedicine (Lond)       Date:  2013-07-09       Impact factor: 5.307

4.  Multi-modal characterization of vasculature and nanoparticle accumulation in five tumor xenograft models.

Authors:  Einar Sulheim; Jana Kim; Annemieke van Wamel; Eugene Kim; Sofie Snipstad; Igor Vidic; Ingeborg Hovde Grimstad; Marius Widerøe; Sverre H Torp; Steinar Lundgren; David J Waxman; Catharina de Lange Davies
Journal:  J Control Release       Date:  2018-04-21       Impact factor: 9.776

Review 5.  Organotropic drug delivery: Synthetic nanoparticles and extracellular vesicles.

Authors:  Sara Busatto; Anthony Pham; Annie Suh; Shane Shapiro; Joy Wolfram
Journal:  Biomed Microdevices       Date:  2019-04-15       Impact factor: 2.838

Review 6.  A holistic approach to targeting disease with polymeric nanoparticles.

Authors:  Christopher J Cheng; Gregory T Tietjen; Jennifer K Saucier-Sawyer; W Mark Saltzman
Journal:  Nat Rev Drug Discov       Date:  2015-01-19       Impact factor: 84.694

7.  Combining hard and soft magnetism into a single core-shell nanoparticle to achieve both hyperthermia and image contrast.

Authors:  Qiuhong Yang; Maogang Gong; Shuang Cai; Ti Zhang; Justin T Douglas; Viktor Chikan; Neal M Davies; Phil Lee; In-Young Choi; Shenqiang Ren; M Laird Forrest
Journal:  Ther Deliv       Date:  2015-10-08

8.  Targeting N-cadherin increases vascular permeability and differentially activates AKT in melanoma.

Authors:  Ryan S Turley; Yoshihiro Tokuhisa; Hiroaki Toshimitsu; Michael E Lidsky; James C Padussis; Andrew Fontanella; Wanleng Deng; Christina K Augustine; Georgia M Beasley; Michael A Davies; Mark W Dewhirst; Douglas S Tyler
Journal:  Ann Surg       Date:  2015-02       Impact factor: 12.969

9.  Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma.

Authors:  Sandhya Pranatharthiharan; Mitesh D Patel; Vinod C Malshe; Vaishali Pujari; Ajit Gorakshakar; Manisha Madkaikar; Kanjaksha Ghosh; Padma V Devarajan
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

10.  Active Tumoral/Tumor Environmental Dual-Targeting by Non-Covalently Arming with Trispecific Antibodies or Dual-Bispecific Antibodies on Docetaxel-Loaded mPEGylated Nanocarriers to Enhance Chemotherapeutic Efficacy and Minimize Systemic Toxicity.

Authors:  Wei-Jie Cheng; Shyr-Yi Lin; Michael Chen; Ling-Chun Chen; Hsiu-O Ho; Kuo-Hsiang Chuang; Ming-Thau Sheu
Journal:  Int J Nanomedicine       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.